DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Firms / Healthcap VII Advisor Ab
Healthcap VII Advisor Ab
Institutional venture firm · probableStockholmhealthcap.euSEC exempt reporting adviserpart of HealthCap
One of 5 advisers that share healthcap.eu; the firm is HealthCap. Healthcap Advisor Ab, Healthcap Ix Advisor Ab, Healthcap Viii Advisor Ab, OFP V Advisor Ab. Each keeps its own CRD, funds and filings; the grouping is the website each swore to on Form ADV and is recomputed every pass.
HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.
venture manager, reported GAV $132M across 1 vehicles
Importance
40
elevated
Active deployment
30
moderate
Emerging
0
low
Completeness
69
high
Freshness
100
high
Research priority
14
low
Identity and regulatory footprint
- Headquarters
- Stockholm, Swedenadviserinfo.sec.gov
- Office address
- ENGELBREKTSPLAN 1, Stockholm, 114 34adviserinfo.sec.gov
- Business phone
- +46 8 4425850adviserinfo.sec.gov
- Website
- HTTPS://WWW.HEALTHCAP.EU
- SEC adviser type
- exempt reporting adviseradviserinfo.sec.gov
- SEC exemption claimed
- private fund adviseradviserinfo.sec.gov
- Latest Form ADV
- May 13, 2024
- Private funds reported
- 1 (1 venture capital funds)adviserinfo.sec.gov
- Private fund gross assets
- $132Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
- Owners on Schedule A
- Lindhold Ab (Direct Owner), A; Healthneed Ab (Direct Owner), B; Ibid Ab (Direct Owner), B; Ellaug Ab (Direct Owner), B; Cantando Ab (Direct Owner), B; Douvelle Ab (Direct Owner), B; Healthback Ab (Shareholder), C; Alfker Ab (Direct Owner), A
- business email
- carl.kilander@healthcap.euhealthcap.eupublished by the subject
- business email
- tyra.kuller@healthcap.euhealthcap.eupublished by the subject
- business phone
- +46 8 4425850adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
40 observed deals
Stated (the firm’s website)
- Sectors
- healthcare, biotech, climate, media
- Stages
- not stated or not yet read
- Geography
- global, globally
- Check size
- not stated; DFX does not estimate checks from round sizes
- Self-described
- venture capital
Observed (from deals on record)
Stage at participation
series a 50%series c 50%
Stage at first entry
series a 50%series c 50%
Sectors
unknown 92%Biotechnology 8%
lead rate 50%follow-on rate 0%new logos, 12 months 40
Funds and vehicles
1 reported
| Vehicle | Type | Vintage | Lifecycle | Reported GAV | Owners | Form D sold | Latest Form D |
|---|---|---|---|---|---|---|---|
| Healthcap VII LP | Fund | 2015 form d first sale | Harvest | $132M May 13, 2024 | 10 | $160M of $220M | Jun 29, 2016 |
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
37 current, 2 departed
Josefine Persson
AssociateAssociate | MSc
Nikolai Paus
AssociateAssociate I BSc
Nima Barati
AssociateMedical Associate I MD
Shamim Dadvar
AssociateAssociate | MD PhD
Thomas Ramdahl
General partnerDirector, GP | MSc PhD
Vanessa Malier
General partnerDirector, GP | MSc
Sofie Wennerqvist
OtherInvestment Monitor
Alex Valcu
PartnerPartner | MSc
Alex Valcu
PartnerOwner · since Oct 1, 2022
Anki Forsberg
PartnerPartner and Chairman | LLM MBA
Carl Kilander
PartnerOwner · since Oct 1, 2022
Carl Kilander
PartnerPartner | MD PhD
Daniel Karsberg
PartnerPartner | MSc
Fabrice Bernhard
PartnerGeneral Manager | MSc
Fabrice Bernhard
PartnerOwner · since Oct 1, 2022
Georg Beiske
PartnerOwner · since Oct 1, 2022
Johan Christenson
PartnerPartner | MD PhD
Johan Christenson
PartnerSole Shareholder · since Mar 1, 2007
Kristina Ekberg
PartnerPartner | LLM
Marile Schiess
PartnerOwner · since Oct 1, 2022
Max Odlander
PartnerOwner · since Oct 1, 2022
Max Odlander
PartnerPartner | MSc
PER Johan Ture Samuelsson
PartnerSole Shareholder · since Aug 1, 2009
Per Samuelsson
PartnerPartner | MSc
Staffan Lindstrand
PartnerPartner | MSc
Staffan Lindstrand
PartnerSole Shareholder · since Dec 1, 2009
Marile Schiess
Platform and operationsHead of Compliance I MSc
Nattiya Simmano
Platform and operationsOffice Manager
ANN Christine Forsberg
PrincipalDirector · since Aug 1, 2015
Bjorn Odlander
PrincipalDirector · since Aug 1, 2015
Kristina Ekberg
PrincipalDirector · since May 1, 2022
Marten Steen
PrincipalDirector · since May 1, 2022
Oern R. Stuge
PrincipalDirector I MD MBA
PER Olof Eriksson
PrincipalDirector · since Aug 1, 2015
Carl-Johan Dalsgaard
Venture partnerVenture Partner | MD PhD
Eugen Steiner
Venture partnerVenture Partner | MD PhD
Georg Vo Beiske
Venture partnerVenture Partner | MSc
2 departed (kept with end dates)
- Jacob Gunterberg · Sole Shareholder · Dec 1, 2009 to Apr 10, 2023 Inference
- Karl Jonas Hansson · Sole Shareholder · Oct 1, 2018 to Apr 10, 2023 Inference
Investments on record
40 edges, 38 companies, 0 partner-attributed
“This investor” is the amount disclosed for this investor alone; it is unknown unless a source said it. The round size is the whole round.
Co-investors
18 relationships from shared deals, counted for the whole firm
Mitsui & Co. Global Investment, Inc. 1 shared · one timeBiogeneration III Services B.V. 1 shared · one timeOmega Fund Management, LLC 1 shared · one timeAsset Management Ventures, LLC 1 shared · one timeSofinnova Investments, Inc. 1 shared · one timeHBM Healthcare Investments 1 shared · one timeGrdnt LLC 1 shared · one timeAvoro Capital Advisors LLC 1 shared · one timeCrane Venture Partners LLP 1 shared · one timeLifeline Ventures 1 shared · one time · we led 1Sandwater 1 shared · one time · they led 1 · we led 1Deep Track Capital 1 shared · one timeSofinnova Partners 1 shared · one time · they led 1Maj Invest Equity 1 shared · one timeNovo Holdings 1 shared · one timeInvus 1 shared · one timeAccess Biotechnology 1 shared · one timeAvoro Ventures 1 shared · one time
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
19 dated events
- Sep 16, 2026Howtogetridofwartshome no longer listed on Healthcap VII Advisor Ab's portfolio pageRemoved from portfolio pagePortfolioInferenceHowtogetridofwartshomeVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026myelodysplastic syndrome no longer listed on Healthcap VII Advisor Ab's portfolio pageRemoved from portfolio pagePortfolioInferencemyelodysplastic syndromeVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026anthracycline extravasation no longer listed on Healthcap VII Advisor Ab's portfolio pageRemoved from portfolio pagePortfolioInferenceanthracycline extravasationVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026heparin-induced thrombocytopenia no longer listed on Healthcap VII Advisor Ab's portfolio pageRemoved from portfolio pagePortfolioInferenceheparin-induced thrombocytopeniaVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026pulmonary embolism no longer listed on Healthcap VII Advisor Ab's portfolio pageRemoved from portfolio pagePortfolioInferencepulmonary embolismVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026deep vein thrombosis no longer listed on Healthcap VII Advisor Ab's portfolio pageRemoved from portfolio pagePortfolioInferencedeep vein thrombosisVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026low molecular weight heparin no longer listed on Healthcap VII Advisor Ab's portfolio pageRemoved from portfolio pagePortfolioInferencelow molecular weight heparinVenture organization websites (about, team, portfolio, thesis, news pages)
- Apr 10, 2023Jacob Gunterberg (Sole Shareholder) no longer on Schedule A of Healthcap VII Advisor Ab
- Apr 10, 2023Karl Jonas Hansson (Sole Shareholder) no longer on Schedule A of Healthcap VII Advisor Ab
- Oct 1, 2022Georg Beiske joined Schedule A of Healthcap VII Advisor Ab as Owner
- Oct 1, 2022Carl Kilander joined Schedule A of Healthcap VII Advisor Ab as Owner
- Oct 1, 2022Alex Valcu joined Schedule A of Healthcap VII Advisor Ab as Owner
- Oct 1, 2022MAX Odlander joined Schedule A of Healthcap VII Advisor Ab as Owner
- Oct 1, 2022Fabrice Bernhard joined Schedule A of Healthcap VII Advisor Ab as Owner
- Oct 1, 2022Marile Schiess joined Schedule A of Healthcap VII Advisor Ab as Owner
- May 1, 2022Kristina Ekberg joined Schedule A of Healthcap VII Advisor Ab as Director
- Oct 1, 2018Karl Jonas Hansson joined Schedule A of Healthcap VII Advisor Ab as Sole Shareholder
- Feb 3, 2016Healthcap VII LP first reported on Form ADV by Healthcap VII Advisor Ab (Venture Capital Fund)Fund first reported on Form ADVFundsFactHealthcap VII LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Feb 3, 2016Healthcap VII Advisor Ab first filed Form ADV (ERA)First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Classification history
- Sep 12, 2026Institutional venture firm (probable, 80%, cls-1)venture manager, reported GAV $132M across 1 vehicles
Evidence
40 observations from 2 sources